Cargando…
Risk factors associated with bleeding after multi antithrombotic therapy during implantation of cardiac implantable electronic devices
Previous studies showed that continuous anticoagulation or single antiplatelet therapy during implantations of cardiac implantable electronic devices (CIED) was relatively safe. However, the safety of continuous multi antithrombotic therapy (AT) in patients undergoing CIED interventions has not been...
Autores principales: | Ishibashi, Kohei, Miyamoto, Koji, Kamakura, Tsukasa, Wada, Mitsuru, Nakajima, Ikutaro, Inoue, Yuko, Okamura, Hideo, Noda, Takashi, Aiba, Takeshi, Kamakura, Shiro, Shimizu, Wataru, Yasuda, Satoshi, Akasaka, Takashi, Kusano, Kengo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334385/ https://www.ncbi.nlm.nih.gov/pubmed/27469320 http://dx.doi.org/10.1007/s00380-016-0879-x |
Ejemplares similares
-
Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
por: Ishibashi, Kohei, et al.
Publicado: (2017) -
Significance of Coronary Artery Spasm Diagnosis in Patients With Early Repolarization Syndrome
por: Kamakura, Tsukasa, et al.
Publicado: (2018) -
T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
por: Kamakura, Tsukasa, et al.
Publicado: (2016) -
Comparing the catheter delivery system and the stylet delivery system for ventricular lead placement in pacemaker implantation—The CATS delivery system randomized controlled trial
por: Yamagata, Kenichiro, et al.
Publicado: (2019) -
Low‐Voltage Type 1 ECG Is Associated With Fatal Ventricular Tachyarrhythmia in Brugada Syndrome
por: Nagase, Satoshi, et al.
Publicado: (2018)